{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:37:04Z","timestamp":1769909824412,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.hpb.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T01:46:25Z","timestamp":1532828785000},"page":"834-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pasireotide is not effective in reducing the development of postoperative pancreatic fistula"],"prefix":"10.1016","volume":"20","author":[{"given":"Stephanie","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis A.","family":"DiFronzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria V.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2018.03.007_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.surg.2005.05.001","article-title":"Postoperative pancreatic fistula: an international study group (ISGPF) definition","volume":"138","author":"Bassi","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2018.03.007_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000658-200009000-00014","article-title":"Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial","volume":"232","author":"Yeo","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2168.2001.01659.x","article-title":"Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials","volume":"88","author":"Li-Ling","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/bjs.5107","article-title":"Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery","volume":"92","author":"Connor","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib5","article-title":"Somatostatin analogues for pancreatic surgery","author":"Gurusamy","year":"2013","journal-title":"Coch Data Syst Rev"},{"key":"10.1016\/j.hpb.2018.03.007_bib6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/hpb.12314","article-title":"Prophylactic octreotide for pancreatoduodenectomy: more harm than good?","volume":"16","author":"McMillan","year":"2014","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.007_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.surg.2016.11.021","article-title":"Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the international study group of pancreatic surgery (ISGPS)","volume":"161","author":"Shrikhande","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2018.03.007_bib8","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa1313688","article-title":"Pasireotide for postoperative pancreatic fistula","volume":"21370","author":"Allen","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2018.03.007_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jso.24239","article-title":"Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes","volume":"113","author":"Abbott","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.007_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/SLA.0000000000001889","article-title":"Pasireotide for the prevention of pancreatic fistula following pancreaticoduodenectomy a cost-effectiveness analysis","volume":"265","author":"Goyert","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/SLA.0000000000001892","article-title":"The cost of postoperative pancreatic fistula versus the cost of pasireotide Results from a prospective Randomized trial","volume":"265","author":"Ma","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SLA.0000000000001975","article-title":"Invited commentary: pasireotide and the prevention of pancreatic fistula after pancreatectomy","volume":"265","author":"Yeo","year":"2017","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.hpb.2018.03.007_bib13","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/SLA.0000000000002225","article-title":"Pasireotide for the prevention of postoperative pancreatic fistula: time to curb the enthusiasm?","volume":"267","author":"Maggino","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/SLA.0b013e31823598fb","article-title":"A\u00a0prognostic score to predict major complications after pancreaticoduodenectomy","volume":"254","author":"Braga","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2012.09.002","article-title":"A\u00a0prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy","volume":"216","author":"Callery","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.hpb.2017.01.022","article-title":"Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception","volume":"19","author":"McMillan","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.007_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11605-016-3340-7","article-title":"Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis","volume":"21","author":"Denbo","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2018.03.007_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SLA.0000000000001537","article-title":"Risk-adjusted outcomes of clinically Relevant pancreatic fistula following pancreatoduodenectomy: a model for performance evaluation","volume":"264","author":"McMillan","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.surg.2015.10.028","article-title":"Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy","volume":"159","author":"McMillan","year":"2016","journal-title":"Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archsurg.143.10.956","article-title":"Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution","volume":"143","author":"Goh","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.hpb.2018.03.007_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1245\/s10434-016-5762-6","article-title":"Type of Resection (Whipple vs. Distal) does not affect the national failure to provide post-resection adjuvant chemotherapy in localized pancreatic cancer","volume":"24","author":"Bergquist","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.007_bib23","article-title":"Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience","author":"Dominguez-Rosado","year":"2017","journal-title":"J\u00a0Am Coll Surg [Internet]"},{"key":"10.1016\/j.hpb.2018.03.007_bib24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1245\/s10434-015-5077-z","article-title":"Health-related quality of life following pancreatectomy: results from a randomized controlled trial","volume":"23","author":"Eaton","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:15:57Z","timestamp":1761264957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X18307822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1365182X18307822"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.007","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pasireotide is not effective in reducing the development of postoperative pancreatic fistula","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}